- Home
- QBTS vs QGEN Comparison
QBTS vs QGEN Comparison
Compare QBTS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QBTS | QGEN |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | QBTS | QGEN |
|---|---|---|
| Price | $23.87 | $45.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $31.23 | ★ $50.07 |
| AVG Volume (30 Days) | ★ 30.3M | 1.2M |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | N/A | ★ 1.84 |
| Revenue | $24,144,000.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $194.34 | $7.12 |
| Revenue Next Year | $56.23 | $6.13 |
| P/E Ratio | ★ N/A | $24.48 |
| Revenue Growth | ★ 156.20 | 5.32 |
| 52 Week Low | $3.74 | $37.63 |
| 52 Week High | $46.75 | $51.88 |
Technical Indicators
Market Signals| Indicator | QBTS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 43.68 |
| Support Level | $23.57 | $44.51 |
| Resistance Level | $29.15 | $45.59 |
| Average True Range (ATR) | 2.37 | 0.62 |
| MACD | 0.14 | -0.17 |
| Stochastic Oscillator | 33.40 | 21.82 |
Price Performance
Historical ComparisonAbout QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).